Adagio Therapeutics Reports That None Of The Mutations Present In SARS-CoV-2 Variant, Omicron, Are Associated With Escape From ADG20 Neutralization In Vitro

by | Nov 29, 2021 | Extra Jobs | 0 comments

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.